Kay Baea
Overview
Explore the profile of Kay Baea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
468
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nsanzabana C, Hastings I, Marfurt J, Muller I, Baea K, Rare L, et al.
J Infect Dis
. 2010 Jan;
201(3):435-43.
PMID: 20047502
BACKGROUND. Antimalarial use is a key factor driving drug resistance and reduced treatment effectiveness in Plasmodium falciparum malaria, but there are few formal, quantitative analyses of this process. METHODS. We...
2.
Falk N, Kaestli M, Qi W, Ott M, Baea K, Cortes A, et al.
J Infect Dis
. 2009 Jun;
200(3):347-56.
PMID: 19552523
Background: The variable antigen P. falciparum erythrocyte membrane protein-1 (PfEMP1) is a major virulence factor in malaria. A large number of var genes encode PfEMP1, and we hypothesized that a...
3.
Genton B, DAcremont V, Rare L, Baea K, Reeder J, Alpers M, et al.
PLoS Med
. 2008 Jun;
5(6):e127.
PMID: 18563961
Background: Severe malaria (SM) is classically associated with Plasmodium falciparum infection. Little information is available on the contribution of P. vivax to severe disease. There are some epidemiological indications that...
4.
Genton B, Baea K, Lorry K, Ginny M, Wines B, Alpers M
P N G Med J
. 2007 Jan;
48(3-4):141-50.
PMID: 17212060
Resistance of Plasmodium falciparum (Pf) and P. vivax (Pv) to standard antimalarials is widespread in Papua New Guinea (PNG). The objective of the study was to assess the rate of...
5.
Kaestli M, Cockburn I, Cortes A, Baea K, Rowe J, Beck H
J Infect Dis
. 2006 May;
193(11):1567-74.
PMID: 16652286
Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a major pathogenicity factor in falciparum malaria that mediates cytoadherence. PfEMP1 is encoded by approximately 60 var genes per haploid genome. Most...
6.
Genton B, Al-Yaman F, Betuela I, Anders R, Saul A, Baea K, et al.
Vaccine
. 2003 Nov;
22(1):30-41.
PMID: 14604568
Combination B is a malaria vaccine that comprises recombinant Plasmodium falciparum (P. falciparum) blood-stage proteins MSP1, MSP2 and RESA, formulated with the adjuvant Montanide ISA 720. A phase I-IIb double-blind...